Your browser doesn't support javascript.
loading
Evaluation of chiral normal-phase liquid chromatography as a secondary tier in pharmaceutical chiral screening strategy.
Tai, Hua-Chia; Lin, Ziqing; Fabiano, Abigail; Zhou, Yiyang; Saurer, Eric M; Ye, Yun K; He, Brian Lingfeng.
Afiliação
  • Tai HC; Chemical Process Development, Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, NJ 08903, USA.
  • Lin Z; Chemical Process Development, Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, NJ 08903, USA. Electronic address: ziqing.lin@bms.com.
  • Fabiano A; Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37202, USA.
  • Zhou Y; Chemical Process Development, Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, NJ 08903, USA.
  • Saurer EM; Chemical Process Development, Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, NJ 08903, USA.
  • Ye YK; Chemical Process Development, Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, NJ 08903, USA.
  • He BL; Chemical Process Development, Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, NJ 08903, USA.
J Chromatogr A ; 1672: 463053, 2022 Jun 07.
Article em En | MEDLINE | ID: mdl-35460990

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromatografia de Fase Reversa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromatografia de Fase Reversa Idioma: En Ano de publicação: 2022 Tipo de documento: Article